Skip to main content
Equibles

STATE STREET CORP

Position in JBIO — Jade Biosciences, Inc.

CIK 93751 BOSTON, MA
Back to JBIO Full portfolio

Position in JBIO

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$51,890,032
+$42,677,588 QoQ
Shares Held
2,335,285
+256.2% QoQ
Ownership
3.67%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
20 quarters on record
Voting authority Sole 9% Shared 0% None 91%

Common Shares in JBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. JBIO ranks #116 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in JBIO

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,890,032 2,335,285
2026-03-31 $9,212,444 655,690
2025-12-31 $9,920,271 642,921
2025-09-30 $4,308,846 499,287
2025-06-30 $3,184,522 318,771